Search - tctmd.com

Displaying 301 - 313 of 313

Sort: Relevancy | Date

News Daily News

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

October 03, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

FDA Panel Recommends Approval of Transcatheter Heart Valve

July 21, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Video

» Topical Discussion

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

February 7, 2024

Video

» Topical Discussion

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

February 6, 2024

Partner Content

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

January 25, 2024

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Video

TVT 2019: Highlights From the Evolut Low-Risk Trial

June 13, 2019

Advertisement

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

ESC Congress 2011: Drugs, Devices Work Together

FDA Panel Recommends Approval of Transcatheter Heart Valve

After GRAVITAS: Is There a Future for Functional Platelet Testing?

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

TVT 2019: Highlights From the Evolut Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content